Watch ICON experts give an in-depth overview of infectious disease modeling with a focus on assessment of interventions and its challenges.
The nature of communicable diseases results in unique epidemiological characteristics that must be accounted for when considering the epidemiological, clinical, and economic consequences of interventions that modify transmission. These interventions clearly include vaccines, but also drug treatments that may reduce the duration of infectiousness.
This webinar outlines the unique epidemiological characteristics of communicable diseases and demonstrates how correctly accounting for these in clinical and economic assessments of interventions can capture the full value of these interventions. Some of the challenges faced when performing these analyses are also addressed.
Presenters
Marija Zivkovic-Gojovic
Marija Zivkovic-Gojovic is experienced in using various types of dynamic modeling algorithms, with expertise in agent-base modeling. Her work includes modeling various disease dynamics like influenza, pertussis, HPV, HIV, HepB, HepC, and COVID-19 and health-economic modeling with an emphasis on health-economic evaluation of vaccine applications.
Richard Pitman
Richard Pitman has over 30 years experience in the epidemiology, burden of illness, and mathematical modeling of infectious diseases, particularly relating to the cost effectiveness of interventions and policy issues. Disease area expertise includes influenza, SARS, rotavirus, respiratory syncytial virus, tuberculosis, directly transmitted childhood infections, and HIV.
Pragya Khurana
Pragya Khurana has focused on epidemiology and data analytics projects within the Real-World Evidence space. She has experience in multiple therapeutic areas, including oncology and infectious diseases. Pragya has a strong understanding of epidemiologic study design and conduct of analysis. She has provided support and insight at various study stages.
Sponsor
ICON
Content Partners
HealthEconomics.com
HealthEconomics.com is the world’s largest Connected Community™ for Value, Evidence and Access in the life sciences industry.
HealthEconomics.com provides a single global link to the health economic and outcomes research (HEOR), real-world evidence (RWE), and Market Access (MA) stakeholder communities. Since 1993, we have provided unparalleled access to drive business, improve knowledge, and connect researchers and payer decision-makers world-wide.
Our 27,000 engaged readers rely on HealthEconomics.com as the most reliable, credible and curated digital hub for the latest news, insights, educational opportunities, and industry benchmarks in HEOR, RWE and MA. Our advertisers, numbering more than 500 with a 91% retention rate, depend upon HealthEconomics.com for best-in-class global brand awareness and business development solutions. Our aim is to connect people with expert-driven content and resources — all in one place — with the corporate mission to advance communication about healthcare value.
